3rd Quarter - Report
TRUSYNERGY for BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)
Firm
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Policy and FDA Policy.
Foreign entity interest: AMO Pharma is dual located in the United Kingdom and the United States.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.